FIELD: medicine.
SUBSTANCE: claimed invention relates to capsule for application with inhalator of dry powder, which contains composition in form of dry powder for pulmonary introduction, which contains mechanosynthesised microparticles, consisting of antibiotic and magnesium stearate.
EFFECT: invention relates to method of obtaining claimed capsule and its application in treatment of bacterial infection, associated with certain lungs diseases.
10 cl, 4 ex, 3 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| INTRAPULMONARY ADMINISTRATION OF FUOROQUINOLONE | 2009 |
|
RU2497524C2 |
| METHODS OF TREATING ENDOBRONCHIAL DISEASES | 2005 |
|
RU2389477C2 |
| COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | 2008 |
|
RU2484823C2 |
| METHOD FOR PRODUCING CARRIER PARTICLES FOR DRY POWDERS FOR INHALATIONS | 2011 |
|
RU2585101C2 |
| COMBINED PREPARATIONS OF AMINOGLYCOSIDES AND PHOSPHOMYCIN, HAVING IMPROVED CHEMICAL PROPERTIES | 2014 |
|
RU2691658C2 |
| TREATMENT OF PULMONARY INFECTIONS BY ADMINISTERING TOBRAMYCIN BY AEROLYSATION | 2011 |
|
RU2597842C2 |
| MICROPARTICLES CONTAINING SULFUR-CONTAINING COMPOUNDS | 2017 |
|
RU2780397C2 |
| INHALATION PHARMACEUTICAL COMPOSITIONS | 2013 |
|
RU2697862C2 |
| PHARMACEUTICAL DRUG FORMS CONTAINING LOW-DOSAGE ACTIVE COMPONENT FOR DRY POWDER INHALATORS | 2005 |
|
RU2371171C2 |
| METHOD OF PRODUCING A DRY POWDER COMPOSITION CONTAINING AN ANTICHOLINERGIC, CORTICOSTEROID AND BETA-ADRENERGIC AGENT | 2018 |
|
RU2741427C1 |
